Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-11-21-Speech-4-093"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-11-21"^^xsd:date2
dcterms:Is Part Of	lp_eu:Vote2
dcterms:Language	"el"^^xsd:language2
lpv:document identification number	"en.20021121.4.4-093"2
lpv:hasSubsequent	lp_eu:2002-11-21-Speech-4-0942
lpv:speaker	lp:Efstratios Korakas2
lpv:spokenAs	member_of_the_bureau; EUL/NGL (1999-10-13--2004-07-19)3 member; Delegation for relations with the NATO Parliamentary Assembly (2002-02-07--2004-07-19)3 unknown; Kommounistiko Komma Elladas (1999-07-20--2004-07-19)3 member; Committee on Foreign Affairs, Human Rights, Common Security and Defence Policy (2002-01-17--2004-07-19)3 substitute; Committee on Regional Policy, Transport and Tourism (2002-01-17--2004-07-19)3 substitute; Delegation to the EU-Turkey Joint Parliamentary Committee (2002-02-07--2004-07-19)3
lpv:translated text	". First, it is right that there should be controls and rules on the herbal medicinal product market, which is in total chaos, leaving the way clear for quacks to profit at the expense of public health and consumers. The question, however, that bother us is how herbal medicinal products are to reach patients and consumers. The report explains that these medicinal products will be available over the counter, thereby shifting the entire responsibility for selecting a suitable product on to the patient or consumer, whose only source of information will be the manufacturer's advertisements. Basically, therefore, consumers will be at the mercy of misleading information from the private sector and large industrial facilities, who will be able to profiteer as they please. The second question which arises is whether these medicinal products should be sold through pharmacies and by qualified pharmacists or whether they will be available on supermarket shelves. Probably the latter, it would appear. We believe that once these preparations are classified – and they must be classified – as a medicinal product, they should be prescribed through the proper channels by a doctor or pharmacist and should be available on the national health."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph